Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic profiling and stable isotope tracing of human schwannomas: A novel perspective on tumor biology and radiation response. | Neurooncol Adv | 2026 | 41635804 | PubTator, text mining | PubMed |
| Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC). | Nat Commun | 2026 | 41634004 | PubTator, text mining | PubMed |
| Momordin Ic suppresses breast cancer growth by targeting ACTL8‑dependent glutamine metabolism and PI3K/AKT/mTOR-MYC. | Biochem Pharmacol | 2026 | 41621692 | PubTator, text mining | PubMed |
| Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression. | Cancer Biol Ther | 2026 | 41606955 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
| Transduction of Quiescent Human Hematopoietic Stem and Progenitor Cells Using Lentiviral Vectors and Virus-Like Particles. | Curr Protoc | 2026 | 41591869 | PubTator, text mining | PubMed |
| Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma: A multi-cohort retrospective study. | Medicine (Baltimore) | 2026 | 41578512 | PubTator, text mining | PubMed |
| Digoxin Attenuates Ocular Hypertension and Protects Trabecular Meshwork Cells via Ferroptosis Inhibition. | Invest Ophthalmol Vis Sci | 2026 | 41563015 | PubTator, text mining | PubMed |
| Notch signaling activation reduces vesicular endocytosis in human pluripotent stem cell-derived CNS-like endothelial cells. | Fluids Barriers CNS | 2026 | 41546116 | PubTator, text mining | PubMed |
| <p>Regulatory networks of HIFs in tumor‑infiltrating immune cells: From molecular mechanisms to therapeutic implications (Review)</p>. | Int J Oncol | 2026 | 41543185 | PubTator, text mining | PubMed |
| Sources and Metabolism of D-Amino Acids and Their Roles as Biomarkers in Kidney Disease: A Review. | Med Sci Monit | 2026 | 41540713 | PubTator, text mining | PubMed |
| Regulatory Mechanism of Glutamine Transporter ASCT2 in Intestinal Health of Piglets and Nutritional Intervention Strategies. | J Agric Food Chem | 2026 | 41499580 | PubTator, text mining | PubMed |
| The regulatory roles and therapeutic strategies of the solute carrier transporters in cancer metabolism. | NPJ Precis Oncol | 2026 | 41486305 | PubTator, text mining | PubMed |
| Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity. | Cell Host Microbe | 2026 | 41483801 | PubTator, text mining | PubMed |
| Nickel refining fumes activate glutamine metabolism via the HIF-1α/Notch pathway to drive epithelial-mesenchymal transition in Beas-2B cells. | Toxicology | 2026 | 41478399 | PubTator, text mining | PubMed |
| Alanine-serine-cysteine transporter-targeted small-molecule boron carriers for neutron capture therapy of L-4‑boronophenylalanine-refractory tumors. | J Control Release | 2026 | 41443347 | PubTator, text mining | PubMed |
| LAT1/SLC7A5-mediated amino acid uptake is regulated by redox signals triggered by formyl-peptide receptor 2. | FEBS J | 2026 | 41422484 | PubTator, text mining | PubMed |
| Low cell density-dependent c-MYC expression determines Aryl Hydrocarbon Receptor nuclear translocation by increasing tryptophan uptake in HeLa cells through the induction of SLC1A5 and SLC3A2. | Biochem Biophys Res Commun | 2026 | 41421222 | PubTator, text mining | PubMed |
| Celastrol delays the progression of hepatocellular carcinoma by suppressing SLC1A5-mediated glutamine dependence. | Toxicol Appl Pharmacol | 2026 | 41401867 | PubTator, text mining | PubMed |
| Glutamine modified lipid nanoparticles loaded with GPX4 siRNA for cervical cancer targeting. | Int J Biol Macromol | 2026 | 41338505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=5